All News

Michael Murphy, PharmD, MBA, provided insights on his research regarding pharmacy deserts, who they impact the most, and the methods needed to improve them in the US.

Addressing harassment, strengthening leadership, and involving frontline pharmacy staff in decision-making are key steps toward a healthier, more supportive work environment.

Flu vaccination significantly reduces illness in vaccinated and unvaccinated individuals, highlighting its importance in public health strategies.

From 2008 to 2023, the relative increase of pediatric patients with obesity classes 4 to 5 was 253.1%.

With an emphasis on the factors that differentiate the future roles of pharmacists, researchers sought to better understand the career intentions of pharmacy students.

Pharmacists are now seeking roles that offer better well-being, flexibility, and long-term satisfaction beyond traditional practice settings.

Pharmacists play a key role in monitoring insulin use by addressing dosing, storage, and symptom management through regular, supportive patient check-ins.

In part 4 of our interview with Michael Kleinrock, lead director of research at IQVIA, he discussed how trends in medication use are currently impacting pharmacy businesses.

The FDA approves Kirsty, an interchangeable biosimilar insulin, enhancing diabetes treatment options and accessibility for patients.

Michael Murphy, PharmD, MBA, discusses how the lack of a universal definition for pharmacy deserts is leading to a significant impact on patients’ access and outcomes.

Community pharmacists play a crucial role in helping patients start insulin with confidence through education, emotional support, and hands-on guidance.

Using the Q Methodology to account for subjectivity in responses, pharmacists self-identified their professional identities.

New study data reveal the waning effectiveness of 2023-2024 COVID-19 vaccines, highlighting the need for ongoing vaccinations and pharmacist involvement.

Older adults with insomnia face heightened depression risks during inflammation, highlighting the need for targeted monitoring and treatment strategies.

In the researchers’ exploration of post-ICU nutritional care, they detailed the clinical pharmacist’s role and provided insights into how this role may evolve in the future.

Perceptions of pharmacy as a long-term career have evolved significantly in recent years due to shifts in education, work roles, and workplace challenges.

Susan Cornell, PharmD, CDCES, FAPhA, FADCES, discusses how pharmacists can explain insulin timing and mealtime coordination effectively to patients.

Emphasizing the pharmacist’s essential role, researchers explored the causes, consequences, and clinical implications of polypharmacy.

This year’s conference is taking place from August 1 to 4 in Cincinnati, Ohio.

IQVIA’s Lead Director of Research Michael Kleinrock discusses how federal policy has been impacting prescription drug costs in the US and where those trends are expected to go.

The new presentation of Shingrix will allow for easier administration.

Brooklyn Morgan, PharmD, discusses the transformation of pharmacy practice from a regulatory model to a more flexible approach.

Pharmacists play a key role in ensuring safe and effective insulin use by identifying common challenges, providing ongoing education, and supporting patient confidence through regular engagement.

Tamara McCants, PharmD, president of NPhA, and Tazche Turner, PharmD, national president of SNPhA, discuss what to expect at this year’s meeting.

Amid increased advancements in diabetes management, Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discussed how these developments are currently impacting the delivery of insulin.

Researchers conducted a review of pharmacist interventions and their ability to impact the outcomes of patients with COPD.

The 2 corporations formed the Bristol Myers Squibb-Pfizer Alliance and will be offering discounted Eliquis to eligible patients starting September 8, 2025.

Jennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM, discusses how pharmacists can collaborate with providers to optimize insulin therapy.